Auro Laboratories Limited

Stock Opportunities Untested - but worth a good look
24

CRISIL ratings update:

  1. “Cash accrual, expected at Rs.5-6 crores in fiscal 2023 and 2024 should comfortably cover debt obligations of Rs 0.32 crore and Rs 2.02 crore, respectively. Fund-based limit of Rs 9 crore was utilised 52% on average during the 12 months through Mar’22.”
  2. Rising raw material costs - biggest threat alongside heavy working capital needs.
  3. Estimated FCF yield for FY23 and FY24 - 10%

https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/AuroLaboratoriesLimited_July%2027,%202022_RR_297583.html

Can’t post till others reply so, I am editing this post:

Q1FY23 results are out, shambolic and abysmal to put it nicely:

Auro laboratories’ operational revenue for the quarter is 11.19 Crs (6.22% YoY and - 37.46% QoQ), its operating profits (OPM - 2.91%) came at .33 Crs (-70.54% YoY and -50.35% QoQ) and its net profits (NPM - 0.77%)came at .08 Crs (-92.25% YoY and -85.4% QoQ).

On a YoY basis, consumption of raw materials remained similar and on a QoQ basis, as a percentage of revenues, it bumped up slightly. The profits have been drawn down mainly due to lower sales and high other expenses.

1 Like